MFine raises USD 48 mn funding from Moore Strategic Ventures, BEENEXT and others

By: |
September 29, 2021 1:38 PM

The series C round also saw participation from existing investors, Stellaris Venture Partners, SBI Group Japan, SBI Ven Capital Singapore, Heritas Capital, Prime Venture Partners, Y'S Investment Pte Ltd and Alteria Capital, a statement said.

fundsThe new round of funding will help MFine invest in expanding its hospital, diagnostics and e-pharmacy network across the country. (Representational image)

Digital health startup MFine on Wednesday said it has raised USD 48 million (about Rs 356.1 crore) in funding, co-led by Moore Strategic Ventures and BEENEXT. The series C round also saw participation from existing investors, Stellaris Venture Partners, SBI Group Japan, SBI Ven Capital Singapore, Heritas Capital, Prime Venture Partners, Y’S Investment Pte Ltd and Alteria Capital, a statement said.

The new round of funding will help MFine invest in expanding its hospital, diagnostics and e-pharmacy network across the country and building tech-driven care delivery products for both acute and chronic conditions patients, it added. MFine was founded in December 2017 by Ashutosh Lawania and Prasad Kompalli, who were later joined by Ajit Narayanan and Arjun Choudhary.

To date it has raised about USD 75 million in equity and debt. Since its inception, over three million users have used MFine services with the platform clocking over three lakh monthly transactions that include doctor consultations, diagnostic tests, e-pharmacy and in-patient procedures.

In October 2018, MFine added another layer to its virtual doctor consultations by integrating with laboratory and diagnostic services and currently, it provides its users access to more than 700 diagnostic centres across 400 cities in India. Over one lakh users use MFine for booking diagnostic tests every month, the statement said. MFine has more than 6,000 doctors across 35 specialties on its platform and serves users in more than 1,000 towns across India.

The company said it is growing at 15 per cent month-on-month, amidst exponential adoption of telemedicine and digital health in India since the onset of the COVID-19 pandemic.

Earlier this year, MFine had launched an app-based SPO2 (blood oxygen saturation) monitoring tool to enable users to keep track of their oxygen saturation levels without needing an additional device. Since then, 2.5 lakh users have used the tool.

In the coming months, MFine will be extending the tool to measure heart rate and blood pressure, the statement said. Over 500 corporates have partnered with MFine to enable services covering over five lakh employees. In the coming months, MFine will bring innovative financial solutions for users together with insurance partners, the statement said.

“In the healthcare sector the world has changed to a new normal and we are seeing a steep growth in the adoption of digital health in India too. We will continue to invest in deep tech to transform every smartphone into a health companion for consumers and a decision support assistant to all doctors,” MFine CEO and co-founder Prasad Kompalli said. He added that the company will also look to expand its network across India and make its services available widely.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1IiAS flags Rs 200-cr debt raising plan by Inox Wind
2Vistara, Lufthansa enter reciprocal partnership for frequent flyer program
3Mahindra Lifespace inks agreement to jointly develop 5-acre housing project in Mumbai region